{"id":"NCT01656161","sponsor":"Debiopharm International SA","briefTitle":"Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer","officialTitle":"A Multicentre, Open, Non-comparative, Phase III Study on the Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 22.5 mg 6-month Formulation in Patients With Advanced Prostate Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2013-08","completion":"2013-08","firstPosted":"2012-08-02","resultsPosted":"2015-09-15","lastUpdate":"2015-09-15"},"enrollment":120,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Triptorelin embonate 22.5 mg","otherNames":["Pamorelin"]}],"arms":[{"label":"Triptorelin embonate 22.5 mg","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study is to evaluate the efficacy of triptorelin embonate 22.5 mg 6-month formulation administered by the subcutaneous (under the skin) route in:\n\n* achieving castrate levels of testosterone (\\< 1.735 nmol/L) on Day 29 \\[i.e., 28 days after investigational medicinal product (IMP) injection\\], and\n* in maintaining serum testosterone castrate levels from Month 2 (Day 57) to end of Month 12 (Day 337) in participants with advanced prostate cancer.","primaryOutcome":{"measure":"Percentage of Participants Achieving and Maintaining Castrate Levels of Serum Testosterone (<1.735 Nmol/L)","timeFrame":"within 337 days","effectByArm":[{"arm":"Triptorelin Embonate 22.5 mg","deltaMin":98.33,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"MALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":10,"countries":["South Africa"]},"refs":{"pmids":["10407987","17096678"],"seeAlso":["http://www.debiopharm.com"]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":120},"commonTop":["Hot flush","Hypertension","Urinary tract infection","Constipation","Lethargy"]}}